Mark Hermes

Mark leads the commercial team at EMSAR as Chief Commercial Officer. With over twenty years of commercial and leadership experience, Mark brings a wide range of medical device expertise and service leadership to the team.

Mark is a proven sales and management leader with a consistent track record of delivering outstanding results in challenging conditions. His approach includes service-oriented leadership and an overriding focus on commercial success through customer satisfaction.

During his tenure at Cardiac Science and Zoll, Mark consistently delivered above market growth as Vice President of US Sales. Since joining the EMSAR team in 2022 — when EMSAR acquired Edge Biomedical — Mark has demonstrated his passion for developing optimal structures, personnel, and team culture, while emphasizing the maximization of opportunities and motivation for both internal and channel partner stakeholders.

Mark holds a Bachelor of Liberal Arts in Biochemistry from the University of Iowa.